According to study results out of Norway, paracetamol, or acetaminophen, exposure in pregnancy and in infancy is associated with a child's allergic disease at the age of 10 years.
According to study results out of Norway, paracetamol, or acetaminophen, exposure in pregnancy and in infancy is associated with a child's allergic disease at the age of 10 years. The study, which relied on structured interviews and clinical examinations, represented a 10-year follow-up of more than 1,000 children in a prospective birth cohort.
Thirty-one mothers reported using paracetamol in the first trimester of their pregnancies, and 32 used it in the second or third trimesters. Eighty-three infants received at least 1 dose of the medication by 6 months of age.
At 10 years of age, children of mothers who had used paracetamol in the first trimester were at increased risk for allergic rhinitis, although the agent was not associated with asthma or allergic sensitization.
COMMENTARY
Here is another in a series of studies linking early exposure to antigens and later increased or decreased atopic disease. Acetaminophen may join the current list of potential offenders, while dirt, peanuts, fish, and others move toward innocence. The factors that are most interesting to me are those that we may be able to control through anticipatory guidance and education. -Michael Burke, MD
The benefits of concurrent fetal and maternal heart rate monitoring
April 17th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Identifying benign lesions in female patients by new algorithm
October 6th 2023In this Q+A interview originally conducted by our sister publication, Contemporary OB/GYN, Peter Minneci, MD, MHSc, discusses a study evaluating a new algorithm capable of accurately identifying benign lesions in female patients.